BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15012749)

  • 1. Current incidence, treatment patterns and outcome of end-stage renal disease among indigenous groups in Australia and New Zealand.
    McDonald SP; Russ GR
    Nephrology (Carlton); 2003 Feb; 8(1):42-8. PubMed ID: 15012749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand.
    McDonald SP; Russ GR
    Kidney Int Suppl; 2003 Feb; (83):S123-7. PubMed ID: 12864890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight change trajectories in Aboriginal and Torres Strait islander Australians after kidney transplantation: a cohort analysis using the Australia and New Zealand Dialysis and Transplant registry (ANZDATA).
    Majoni SW; Ullah S; Collett J; Hughes JT; McDonald S
    BMC Nephrol; 2019 Jun; 20(1):232. PubMed ID: 31238893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand.
    Hill K; Ward P; Grace BS; Gleadle J
    BMC Public Health; 2017 Oct; 17(1):802. PubMed ID: 29020957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
    Huria T; Palmer S; Beckert L; Williman J; Pitama S
    Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians.
    Stewart JH; McCredie MR; McDonald SP
    Nephrol Dial Transplant; 2004 Mar; 19(3):678-85. PubMed ID: 14767026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
    Stewart JH; McCredie MR; Williams SM; McDonald SP
    Nephrology (Carlton); 2004 Aug; 9(4):238-46. PubMed ID: 15363056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional variation in the incidence of end-stage renal disease in Indigenous Australians.
    Cass A; Cunningham J; Wang Z; Hoy W
    Med J Aust; 2001 Jul; 175(1):24-7. PubMed ID: 11476198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and treatment of ESRD among indigenous peoples of Australasia.
    McDonald S
    Clin Nephrol; 2010 Nov; 74 Suppl 1():S28-31. PubMed ID: 20979960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: report on dialysis and renal transplantation treatment from the Australia and New Zealand Dialysis and Transplant Registry.
    Disney AP
    Am J Kidney Dis; 1995 Jan; 25(1):165-75. PubMed ID: 7810521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage kidney disease among indigenous peoples of Australia and New Zealand.
    McDonald SP
    Kidney Int Suppl (2011); 2013 May; 3(2):170-173. PubMed ID: 25018983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of dialysis in indigenous compared to nonindigenous Australians.
    Khanal N; Clayton P; McDonald S; Jose M
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):123-127. PubMed ID: 27469158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An epidemic of renal failure among Australian Aboriginals.
    Spencer JL; Silva DT; Snelling P; Hoy WE
    Med J Aust; 1998 Jun; 168(11):537-41. PubMed ID: 9640302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
    Foote C; Clayton PA; Johnson DW; Jardine M; Snelling P; Cass A
    Am J Kidney Dis; 2014 Sep; 64(3):359-66. PubMed ID: 24787762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.